NICE management of acne guideline
This Guidelines summary covers the management of acne in primary care, including advice on treatments and the impact on mental health and wellbeing
NICE secondary bacterial infection of common skin conditions
This Guidelines summary covers an antimicrobial prescribing strategy for secondary bacterial infection of eczema and covers infection of other common skin conditions
COVID-19 rapid guideline on dermatological conditions
The purpose of this Guidelines summary is to maximise the safety of children and adults who have dermatological conditions treated with drugs affecting the immune response during the COVID-19 pandemic
NICE eczema in under 12s guideline
An easy-to-follow NICE guideline summary on the management of atopic eczema in children under 12
NICE guideline on the treatment of human and animal bites
This NICE guideline summary sets out an antimicrobial prescribing strategy for human and animal bites (excluding insect bites) in adults, young people and children aged 72 hours and over
NICE impetigo guideline
This guideline sets out an antimicrobial prescribing strategy for adults, young people, and children aged 72 hours and over with impetigo. It aims to optimise antibiotic use and reduce antibiotic resistance.
NICE leg ulcer infection guideline
This guideline sets out an antimicrobial prescribing strategy for adults with leg ulcer infection. It aims to optimise antibiotic use and reduce antibiotic resistance.
PCDS adult eczema pathway
A concise, helpful summary of the PCDS treatment pathway for the assessment and management of adult eczema
PCDS rosacea treatment pathway guideline
A clear summary of the PCDS guidance on the diagnosis and treatment of rosacea.
NICE pressure ulcer guideline
An up-to-date summary of the NICE guideline on the prevention and management of pressure ulcers in neonates, infants, children, young people, and adults
Educational resources
Managing acne well—a summary of the 2021 NICE guideline
Information intended for UK healthcare professionals only. This promotional supplement has been commissioned and funded by Galderma and developed in partnership with Guidelines.
View Epiduo Gel 0.1% (0.1% adapalene & 2.5% benzoyl peroxide) prescribing information and adverse event reporting information.
View Epiduo Gel 0.3%/2.5 % (0.3% adapalene & 2.5% benzoyl peroxide) prescribing information and adverse event reporting information.
UKI-EDG-2100027
Date of preparation: October 2021